Analytical Data
-
基因名
DIDO1
- Application
-
别名
BYE1; DATF1; DIDO2; DIDO3; DIO1; Death Associated Transcription Factor 1
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BTC0
-
表达区间
Lys258~Cys455
-
分子量
31kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
DIDO1, or Dido homolog 1, is a protein associated with various cellular processes, including apoptosis, cell differentiation, and immune responses. Recent studies have indicated that DIDO1 may play a significant role in the pathogenesis of several diseases, including cancer and neurodegenerative disorders, due to its involvement in regulating gene expression and cellular signaling pathways. The recombinant expression of DIDO1 allows researchers to produce large quantities of this protein for detailed functional studies and therapeutic investigations. Understanding its structure and function in a controlled environment is crucial for elucidating its mechanisms in disease and identifying potential targets for drug development. Recent advances in recombinant DNA technology have facilitated the efficient production of DIDO1, enabling scientists to explore its biochemical properties, interaction partners, and regulatory roles within the cell. Furthermore, the generation of recombinant DIDO1 offers a valuable tool for high-throughput screening assays, potentially leading to novel therapeutic strategies aimed at modulating its activity in disease contexts. Overall, the study of DIDO1 recombinant protein is essential for uncovering its biological significance and therapeutic potential, opening avenues for future research and clinical applications.
